Abstract
DOC-2/hDab-2 was identified due to the loss of its expression in primary ovarian cancer cells. It is believed that loss of DOC-2/hDab-2 expression is one of the early events of ovarian malignancy. These results suggest a function of DOC-2/hDab-2 as a tumor suppressor. However, it is not clear how DOC-2/hDab-2 negatively regulates cancer cell growth. In this report, we demonstrate that DOC-2/hDab-2 expression in breast cancer cells resulted in sensitivity to suspension-induced cell death (anoikis). This event was associated with the down-regulation of the integrin-linked kinase (ILK) activity. Since ILK is a key factor in regulating the cellular signaling in responding to the extracellular signals through adhesion molecules like integrins, our results indicate that DOC-2/hDab-2 may prevent tumor growth and invasion by modulating the anti-apoptotic ILK pathway.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Attwell S, Roskelley C, Dedhar S . 2000 Oncogene 19: 3811–3815
Dedhar S . 2000 Curr. Opin. Cell Biol. 12: 250–256
Delcommenne M, Tan C, Gary V, Rue L, Woodgett J, Dedhar S . 1998 Proc. Natl. Acad. Sci. USA 95: 11211–11216
Fazili Z, Sun W, Mittelstaedt S, Cohen C, Xu X-X . 1999 Oncogene 18: 3104–3113
Gu H, Maeda H, Moon JJ, Lord JD, Yoakim M, Nelson BH, Neel BG . 2000 Mol. Cell. Biol. 20: 7109–7120
Mok SC, Wong KK, Chan RKW, Ching CC, Tsao SW, Knapp RC, Berkowitz RS . 1994 Gynecol. Oncol. 52: 247–252
Mok SC, Chan WY, Wong KK, Cheung KK, Lau CC, Ng SW, Baldini A, Colitti CV, Rock CO, Berkowitz RS . 1998 Oncogene 16: 2381–2387
Persad S, Attwell S, Gray V, Delcommenne M, Troussard A, Sanghera J, Dedhar S . 2000 Proc. Natl. Acad. Sci. USA 97: 3207–3212
Sheng Z, Sun W, Smith E, Cohen C, Sheng Z, Xu X-X . 2000 Oncogene 19: 4847–4854
Toker A, Cantley LC . 1997 Nature 387: 673–676
Xu X-X, Yang W, Jackowski S, Rock CO . 1995 J. Biol. Chem. 270: 14184–14191
Xu X-X, Yi T, Tang B, Lambeth JD . 1998 Oncogene 16: 1561–1569
Yu D, Hung M-C . 1991 Oncogene 6: 1991–1996
Zhou J, Hsieh J-T . 2001 J. Biol. Chem. 276: 27793–27798
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, SC., Makino, K., Xia, W. et al. DOC-2/hDab-2 inhibits ILK activity and induces anoikis in breast cancer cells through an Akt-independent pathway. Oncogene 20, 6960–6964 (2001). https://doi.org/10.1038/sj.onc.1204873
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204873
- Springer Nature Limited
Keywords
This article is cited by
-
Disable 2, A Versatile Tissue Matrix Multifunctional Scaffold Protein with Multifaceted Signaling: Unveiling Role in Breast Cancer for Therapeutic Revolution
Cell Biochemistry and Biophysics (2024)
-
Disabled-2, a versatile tissue matrix multifunctional scaffold protein with multifaceted signaling: Unveiling its potential in the cancer battle
Naunyn-Schmiedeberg's Archives of Pharmacology (2024)
-
Anoikis resistance––protagonists of breast cancer cells survive and metastasize after ECM detachment
Cell Communication and Signaling (2023)
-
ILK silencing inhibits migration and invasion of more invasive glioblastoma cells by downregulating ROCK1 and Fascin-1
Molecular and Cellular Biochemistry (2020)
-
Transcription profiles of non-immortalized breast cancer cell lines
BMC Cancer (2006)